Gilead Acquires Interius BioTherapeutics to Advance Next-Gen Cell Therapy
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best growth stocks to buy for the next 2 years. On August…
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best growth stocks to buy for the next 2 years. On August…
By Karen Roman Toronto-based biotech company Radiant Biotherapeutics announced the designation of Deborah Geraghty, Ph.D., as President and Chief Executive…
There’s nothing like a top-level management departure to get investors worried about a publicly traded company. Investors in biotech stock…